Bo Lin

1.2k total citations
52 papers, 906 citations indexed

About

Bo Lin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bo Lin has authored 52 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Bo Lin's work include Nicotinic Acetylcholine Receptors Study (7 papers), Epigenetics and DNA Methylation (6 papers) and RNA modifications and cancer (6 papers). Bo Lin is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (7 papers), Epigenetics and DNA Methylation (6 papers) and RNA modifications and cancer (6 papers). Bo Lin collaborates with scholars based in China, United States and Hong Kong. Bo Lin's co-authors include Mengsen Li, Mingyue Zhu, Yan Lu, Wei Li, Junli Guo, Yi Chen, Dong Xu, Dong Xu, Wenting Wang and Xieju Xie and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Bo Lin

46 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Lin China 16 521 248 183 138 100 52 906
Hong Zhu China 19 450 0.9× 299 1.2× 136 0.7× 131 0.9× 165 1.6× 54 803
Xu He China 19 358 0.7× 281 1.1× 213 1.2× 212 1.5× 74 0.7× 49 912
Xinzheng Dai China 18 407 0.8× 196 0.8× 196 1.1× 101 0.7× 83 0.8× 29 877
Shuang Lin China 15 442 0.8× 255 1.0× 163 0.9× 67 0.5× 69 0.7× 34 778
Chloé Sauzay France 12 329 0.6× 204 0.8× 150 0.8× 105 0.8× 112 1.1× 19 671
Longying Jiang China 18 549 1.1× 124 0.5× 305 1.7× 107 0.8× 151 1.5× 37 1.3k
Andrea Bandino Italy 12 366 0.7× 200 0.8× 210 1.1× 65 0.5× 82 0.8× 16 730
Yulin Sun China 20 649 1.2× 375 1.5× 231 1.3× 54 0.4× 64 0.6× 56 1.0k
Hongmei Cui China 19 712 1.4× 513 2.1× 130 0.7× 89 0.6× 158 1.6× 34 1.1k
Shuling Huang China 16 444 0.9× 164 0.7× 278 1.5× 64 0.5× 122 1.2× 25 854

Countries citing papers authored by Bo Lin

Since Specialization
Citations

This map shows the geographic impact of Bo Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Lin more than expected).

Fields of papers citing papers by Bo Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Lin. The network helps show where Bo Lin may publish in the future.

Co-authorship network of co-authors of Bo Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Lin. A scholar is included among the top collaborators of Bo Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Lin. Bo Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Bo, Yuling Chen, Xiaolian Li, et al.. (2025). Integrated analysis of FANCE expression and its regulatory role in the immune microenvironment of oral squamous cell carcinoma. Oncology Letters. 29(3). 160–160. 1 indexed citations
2.
Zhang, Chao, Yi Chen, Wei Li, et al.. (2025). AFP promotes cancer multidrug resistance through activating PI3K/Akt/NF-κB signaling pathway. Scientific Reports. 16(1). 590–590.
3.
Liu, Jinchen, Haifeng Lin, Bo Lin, et al.. (2024). IL-6/STAT3 signaling pathway induces prostate apoptosis response protein-4(PAR-4) to stimulate malignant behaviors of hepatocellular carcinoma cells. Annals of Hepatology. 29(6). 101538–101538. 1 indexed citations
4.
Xie, Jindong, Bo Lin, Weihong Tian, et al.. (2024). Pan‐Cancer Single‐Cell and Spatial‐Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy. Advanced Science. 11(23). e2401061–e2401061. 35 indexed citations
5.
Zhao, Hongying, Ke Feng, Junjie Lei, et al.. (2024). Identification of somatic mutation-driven enhancers and their clinical utility in breast cancer. iScience. 27(2). 108780–108780. 1 indexed citations
6.
Huang, Yongyang, et al.. (2024). A Multiplex Assay to Simultaneously Monitor Apoptosis and Necrosis Using the Cellaca® PLX Image Cytometer. Journal of Fluorescence. 35(2). 1111–1123.
7.
Nitta, Carolina Franco, Jeanne Elia, Henry Qazi, et al.. (2023). A rapid and high-throughput T cell immunophenotyping assay for cellular therapy bioprocess using the Cellaca PLX image cytometer. The Journal of Immunology. 210(Supplement_1). 250.06–250.06.
8.
9.
Huang, Yongyang, Rachel Watkins, Samir Patel, et al.. (2023). Practical Characterization Strategies for Comparison, Qualification, and Selection of Cell Viability Detection Methods for Cellular Therapeutic Product Development and Manufacturing. Journal of Fluorescence. 34(5). 2263–2278. 3 indexed citations
10.
Chen, Xiaobing, Wei Li, Dong Xu, et al.. (2023). α-Conotoxin recombinant protein ImI-AFP3 efficiently inhibits the growth and migration of lung cancer cells. Protein Expression and Purification. 215. 106405–106405.
11.
Zhang, Qiuyue, et al.. (2023). Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells. SHILAP Revista de lepidopterología. 4(3). 519–536. 10 indexed citations
12.
Gao, Bingmiao, Yu Huang, Chao Peng, et al.. (2022). High-Throughput Prediction and Design of Novel Conopeptides for Biomedical Research and Development. SHILAP Revista de lepidopterología. 2022. 9895270–9895270. 2 indexed citations
13.
Lin, Bo, et al.. (2022). Vincosamide Has a Function for Inhibiting Malignant Behaviors of Hepatocellular Carcinoma Cells. World Journal of Oncology. 13(5). 272–288. 1 indexed citations
14.
Li, Jie, Xinya Gao, Zhanqiang Zhang, et al.. (2021). CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502–5p/KRAS and IGF2BP2/Myc axes. Molecular Cancer. 20(1). 138–138. 82 indexed citations
15.
Lin, Bo, et al.. (2021). Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer. Frontiers in Oncology. 11. 625936–625936. 10 indexed citations
16.
Gao, Bingmiao, Chao Peng, Bo Lin, et al.. (2017). Screening and Validation of Highly-Efficient Insecticidal Conotoxins from a Transcriptome-Based Dataset of Chinese Tubular Cone Snail. Toxins. 9(7). 214–214. 18 indexed citations
17.
Lin, Bo, Wei Li, Dong Xu, et al.. (2017). Purification and characterization of a bioactive alpha-fetoprotein produced by HEK-293 cells. Protein Expression and Purification. 136. 1–6. 5 indexed citations
18.
Wang, Jian, et al.. (2017). Clinical significance and prognostic value of SOX7 expression in liver and pancreatic carcinoma. Molecular Medicine Reports. 16(1). 499–506. 11 indexed citations
19.
Lin, Bo, et al.. (2014). Efficient Expression of Acetylcholine-Binding Protein fromAplysia californicain Bac-to-Bac System. BioMed Research International. 2014. 1–9. 6 indexed citations
20.
Gao, Bingmiao, Dongting Zhangsun, Yong Wu, et al.. (2012). Expression, renaturation and biological activity of recombinant conotoxin GeXIVAWT. Applied Microbiology and Biotechnology. 97(3). 1223–1230. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Zhu Breakdown of academic impact, for papers by Xu He Breakdown of academic impact, for papers by Xinzheng Dai Breakdown of academic impact, for papers by Shuang Lin Breakdown of academic impact, for papers by Chloé Sauzay Breakdown of academic impact, for papers by Longying Jiang Breakdown of academic impact, for papers by Andrea Bandino Breakdown of academic impact, for papers by Yulin Sun Breakdown of academic impact, for papers by Hongmei Cui Breakdown of academic impact, for papers by Shuling Huang
Rankless by CCL
2026